中国胸心血管外科临床杂志

中国胸心血管外科临床杂志

经导管主动脉瓣置换术并发症的最新进展

查看全文

外科主动脉瓣置换是治疗主动脉瓣狭窄的首选方式,能够显著改善患者生活质量及预期寿命,但部分患者存在高龄、一般情况差等风险而无法开胸手术。2002 年法国医生 Cribier 对 1 例主动脉瓣狭窄患者成功实施经导管主动脉瓣置换术(transcatheter aortic valve implantation,TAVI)手术,目前 TAVI 手术的安全性与有效性,已经被多项研究证实。然而其并发症也相对多见,现就国内外相关报道进行综述。

Surgical aortic valve replacement is the primary choice for the treatment of aortic valve stenosis. It can significantly improve the quality of life and life expectancy of patients, but some patients have risks such as advanced age and poor general conditions and cannot open chest surgery. In 2002, a French doctor, Cribier, successfully performed transcatheter aortic valve implantation (TAVI) surgery on a patient with aortic stenosis. At present, the safety and effectiveness of TAVI surgery have been confirmed by many studies. However, its complications are also relatively common. This article summarizes the related reports at home and abroad.

关键词: 经导管主动脉瓣置换; 并发症; 综述

Key words: Transcatheter aortic valve implantation; complications; review

登录后 ,请手动点击刷新查看全文内容。 没有账号,
1. Cribier A, Eltchaninoff H, Bash A, et al. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation, 2002, 106(24): 3006-3008.
2. Kodali S, Pibarot P, Douglas PS, et al. Paravalvular regurgitation after transcatheter aortic valve replacement with the Edwards sapien valve in the PARTNER trial: characterizing patients and impact on outcomes. Eur Heart J, 2015, 36(7): 449-456.
3. Pibarot P, Hahn RT, Weissman NJ, et al. Association of Paravalvular Regurgitation With 1-Year Outcomes After Transcatheter Aortic Valve Replacement With the SAPIEN 3 Valve. JAMA Cardiol, 2017, 2(11): 1208-1216.
4. O'Sullivan KE, Gough A, Segurado R, et al. Is valve choice a significant determinant of paravalular leak post-transcatheter aortic valve implantation? A systematic review and meta-analysis. Eur J Cardiothorac Surg, 2014, 45(5): 826-833.
5. Sinning JM, Stundl A, Pingel S, et al. Pre-procedural hemodynamic status improves the discriminatory value of the aortic regurgitation index in patients undergoing transcatheter aortic valve replacement. JACC Cardiovasc Interv, 2016, 9(7): 700-711.
6. Sakrana AA, Nasr MM, Ashamallah GA, et al. Paravalvular leak after transcatheter aortic valve implantation: is it anatomically predictable or procedurally determined? MDCT study. Clin Radiol, 2016, 71(11): 1095-1103.
7. Waterbury TM, Reeder GS, Pislaru SV, et al. Techniques and outcomes of paravalvular leak repair after transcatheter aortic valve replacement. Catheter Cardiovasc Interv, 2017, 90(5): 870-877.
8. Wells JA 4th, Condado JF, Kamioka N, et al. Outcomes after paravalvular leak closure: transcatheter versus surgical approaches. JACC Cardiovasc Interv, 2017, 10(5): 500-507.
9. Elhmidi Y, Bleiziffer S, Deutsch MA, et al. Acute kidney injury after transcatheter aortic valve implantation: incidence, predictors and impact on mortality. Arch Cardiovasc Dis, 2014, 107(2): 133-139.
10. Lameire N, Van Biesen W, Vanholder R. The changing epidemiology of acute renal failure. Nat Clin Pract Nephrol, 2006, 2(7): 364-377.
11. Thongprayoon C, Cheungpasitporn W, Mao MA, et al. Persistent acute kidney injury following transcatheter aortic valve replacement. J Card Surg, 2017, 32(9): 550-555.
12. Crowhurst JA, Savage M, Subban V, et al. Factors contributing to acute kidney injury and the impact on mortality in patients undergoing transcatheter aortic valve replacement. Heart Lung Circ, 2016, 25(3): 282-289.
13. Urena M, Hayek S, Cheema AN, et al. Arrhythmia burden in elderly patients with severe aortic stenosis as determined by continuous electrocardiographic recording: toward a better understanding of arrhythmic events after transcatheter aortic valve replacement. Circulation, 2015, 131(5): 469-477.
14. Auffret V, Regueiro A, Del Trigo M, et al. Predictors of early cerebrovascular events in patients with aortic stenosis undergoing transcatheter aortic valve replacement. J Am Coll Cardiol, 2016, 68(7): 673-684.
15. Biancari F, Rosato S, D'Errigo P, et al. Immediate and intermediate outcome after transapical versus transfemoral transcatheter aortic valve replacement. Am J Cardiol, 2016, 117(2): 245-251.
16. Lansky AJ, Schofer J, Tchetche D, et al. A prospective randomized evaluation of the TriGuardTM HDH embolic DEFLECTion device during transcatheter aortic valve implantation: results from the DEFLECT III trial. Eur Heart J, 2015, 36(31): 2070-2078.
17. Kapadia SR, Kodali S, Makkar R, et al. Protection against cerebral embolism during transcatheter aortic valve replacement. J Am Coll Cardiol, 2017, 69(4): 367-377.
18. Kim RJ, McGehee E, Mack MJ. Left main occlusion secondary to aortic root rupture following transcatheter aortic valve replacement managed by left main stenting. Catheter Cardiovasc Interv, 2014, 83(1): E146-E149.
19. Ramirez R, Ovakimyan O, Lasam G, et al. A very late presentation of a right coronary artery occlusion after transcatheter aortic valve replacement. Cardiol Res, 2017, 8(3): 131-133.
20. Sultan I, Siki M, Wallen T, et al. Management of coronary obstruction following transcatheter aortic valve replacement. J Card Surg, 2017, 32(12): 777-781.
21. Pilgrim T, Windecker S. Newer-generation devices for transcatheter aortic valve replacement: resolving the limitations of first-generation valves? JACC Cardiovasc Interv, 2016, 9(4): 373-375.
22. Ribeiro HB, Rodés-Cabau J, Blanke P, et al. Incidence, predictors, and clinical outcomes of coronary obstruction following transcatheter aortic valve replacement for degenerative bioprosthetic surgical valves: insights from the VIVID registry. Eur Heart J, 2018, 39(8): 687-695.
23. Holmes DR Jr, Nishimura RA, Grover FL, et al. Annual outcomes with transcatheter valve therapy: From the STS/ACC TVT Registry. Ann Thorac Surg, 2016, 101(2): 789-800.
24. Tanawuttiwat T, O'Neill BP, Cohen MG, et al. New-onset atrial fibrillation after aortic valve replacement: comparison of transfemoral, transapical, transaortic, and surgical approaches. J Am Coll Cardiol, 2014, 63(15): 1510-1519.
25. Levy F, Tribouilloy C. Letter by levy and tribouilloy regarding article, "atrial fibrillation is associated with increased mortality in patients undergoing transcatheter aortic valve replacement: insights from the placement of aortic transcatheter valve (PARTNER) trial". Circ Cardiovasc Interv, 2016, 9(5): e003705.
26. Abdul-Jawad Altisent O, Durand E, Muñoz-García AJ, et al. Warfarin and antiplatelet therapy versus warfarin alone for treating patients with atrial fibrillation undergoing transcatheter aortic valve replacement. JACC Cardiovasc Interv, 2016, 9(16): 1706-1717.
27. Sager SJ, Damluji AA, Cohen JA, et al. Transient and persistent conduction abnormalities following transcatheter aortic valve replacement with the Edwards-Sapien prosthesis: a comparison between antegrade vs. retrograde approaches. J Interv Card Electrophysiol, 2016, 47(2): 143-151.
28. Gonska B, Seeger J, Baarts J, et al. The balloon-expandable Edwards Sapien 3 valve is superior to the self-expanding Medtronic CoreValve in patients with severe aortic stenosis undergoing transfemoral aortic valve implantation. J Cardiol, 2017, 69(6): 877-882.
29. Siontis GC, Jüni P, Pilgrim T, et al. Predictors of permanent pacemaker implantation in patients with severe aortic stenosis undergoing TAVR: a meta-analysis. J Am Coll Cardiol, 2014, 64(2): 129-140.
30. Arai T, Romano M, Lefèvre T, et al. Direct comparison of feasibility and safety of transfemoral versus transaortic versus transapical transcatheter aortic valve replacement. JACC Cardiovasc Interv, 2016, 9(22): 2320-2325.
31. Wang J, Yu W, Jin Q, et al. Risk factors for Post-TAVI bleeding according to the varc-2 bleeding definition and effect of the bleeding on short-term mortality: a meta-analysis. Can J Cardiol, 2017, 33(4): 525-534.
32. Sun Y, Liu X, Chen Z, et al. Meta-analysis of predictors of early severe bleeding in patients who underwent transcatheter aortic valve implantation. Am J Cardiol, 2017, 120(4): 655-661.
33. Showkathali R, Dworakowski R, MacCarthy P. Valve in valve implantation to prevent acute prosthetic valve migration in Transcatheter Aortic Valve Implantation (TAVI). Indian Heart J, 2015, 67(6): 598-599.
34. Amat-Santos IJ, Messika-Zeitoun D, Eltchaninoff H, et al. Infective endocarditis after transcatheter aortic valve implantation: results from a large multicenter registry. Circulation, 2015, 131(18): 1566-1574.
35. Ko TY, Lin MS, Lin LC, et al. Frequency and Significance of intravascular hemolysis before and after transcatheter aortic valve implantation in patients with severe aortic stenosis. Am J Cardiol, 2018, 121(1): 69-72.
36. Silva LS, Caramori PR, Nunes Filho AC, et al. Performance of surgical risk scores to predict mortality after transcatheter aortic valve implantation. Arq Bras Cardiol, 2015, 105(3): 241-247.
37. Gurvitch R, Tay EL, Wijesinghe N, et al. Transcatheter aortic valve implantation: lessons from the learning curve of the first 270 high-risk patients. Catheter Cardiovasc Interv, 2011, 78(7): 977-984.